These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3754098)

  • 1. The effects of atracurium besylate (Tracrium) on intracranial pressure and cerebral perfusion pressure.
    Rosa G; Orfei P; Sanfilippo M; Vilardi V; Gasparetto A
    Anesth Analg; 1986 Apr; 65(4):381-4. PubMed ID: 3754098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial pressure after atracurium in neurosurgical patients.
    Minton MD; Stirt JA; Bedford RF; Haworth C
    Anesth Analg; 1985 Nov; 64(11):1113-6. PubMed ID: 2932038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myorelaxants and intracranial pressure (ICP) in neurosurgery. Preliminary clinical results of pipecurium bromide (Arduan) on ICP and on cerebral perfusion pressure (CPP)].
    Di Giugno G; Sanfilippo M; Orfei P; Rosa G
    Minerva Anestesiol; 1992 Apr; 58(4 Suppl 1):83-6. PubMed ID: 1320223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cerebral and cardiovascular effects of cisatracurium and atracurium in neurosurgical patients.
    Schramm WM; Papousek A; Michalek-Sauberer A; Czech T; Illievich U
    Anesth Analg; 1998 Jan; 86(1):123-7. PubMed ID: 9428865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.
    Basta SJ; Ali HH; Savarese JJ; Sunder N; Gionfriddo M; Cloutier G; Lineberry C; Cato AE
    Anesth Analg; 1982 Sep; 61(9):723-9. PubMed ID: 6213181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of pipecuronium bromide on intracranial pressure and cerebral perfusion pressure.
    Rosa G; Sanfilippo M; Orfei P; Di Giugno G; Vilardi V; Oppido PA; Gasparetto A
    J Neurosurg Anesthesiol; 1991 Dec; 3(4):253-7. PubMed ID: 15815419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of atracurium in surgical patients under nitrous oxide, oxygen and isoflurane anaesthesia.
    Sokoll MD; Gergis SD; Mehta M; Kemmotsu O; Rudd D
    Br J Anaesth; 1983; 55 Suppl 1():77S-79S. PubMed ID: 6688022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine.
    Basta SJ; Savarese JJ; Ali HH; Moss J; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():105S-106S. PubMed ID: 6190488
    [No Abstract]   [Full Text] [Related]  

  • 9. Histaminoid responses to atracurium, vecuronium and tubocurarine.
    Lavery GG; Clarke RS; Watkins J
    Ann Fr Anesth Reanim; 1985; 4(2):180-3. PubMed ID: 2408513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of atracurium and tubocurarine on heart rate and arterial pressure in anaesthetized man.
    Barnes PK; Thomas VJ; Boyd I; Hollway T
    Br J Anaesth; 1983; 55 Suppl 1():91S-94S. PubMed ID: 6688026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia.
    Foldes FF; Nagashima H; Boros M; Tassonyi E; Fitzal S; Agoston S
    Br J Anaesth; 1983; 55 Suppl 1():97S-103S. PubMed ID: 6190489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular and cardiovascular effects of atracurium in ponies anesthetized with halothane.
    Hildebrand SV; Howitt GA; Arpin D
    Am J Vet Res; 1986 May; 47(5):1096-100. PubMed ID: 3755016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane anaesthesia.
    Rupp SM; Fahey MR; Miller RD
    Br J Anaesth; 1983; 55 Suppl 1():67S-70S. PubMed ID: 6688020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of atracurium in infants.
    Brandom BW; Woelfel SK; Cook DR; Fehr BL; Rudd GD
    Anesth Analg; 1984 Mar; 63(3):309-12. PubMed ID: 6322615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of bolus injections of atracurium in patients with coronary artery disease.
    Philbin DM; Machaj VR; Tomichek RC; Schneider RC; Alban JC; Lowenstein E; Lineberry CC
    Br J Anaesth; 1983; 55 Suppl 1():131S-134S. PubMed ID: 6688008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular blocking action of atracurium in the dog and its reversal by neostigmine.
    Jones RS; Hunter JM; Utting JE
    Res Vet Sci; 1983 Mar; 34(2):173-6. PubMed ID: 6687951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy of cisatracurium and atracurium in kidney transplantation operation.
    Jirasiritham S; Tantivitayatan K; Jirasiritham S
    J Med Assoc Thai; 2004 Jan; 87(1):73-9. PubMed ID: 14971538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromyographic assessment of neuromuscular blockade induced by atracurium.
    Calvey TN; Macmillan RR; West DM; Williams NE
    Br J Anaesth; 1983; 55 Suppl 1():57S-62S. PubMed ID: 6305381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cisatracurium on cerebral and cardiovascular hemodynamics in patients with severe brain injury.
    Schramm WM; Jesenko R; Bartunek A; Gilly H
    Acta Anaesthesiol Scand; 1997 Nov; 41(10):1319-23. PubMed ID: 9422299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil.
    Bourgoin A; Albanèse J; Wereszczynski N; Charbit M; Vialet R; Martin C
    Crit Care Med; 2003 Mar; 31(3):711-7. PubMed ID: 12626974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.